YVONNE GONZALEZ ROGERS, District Judge.
Plaintiffs bring this action against defendant QD Vision, Inc. ("QDV") for alleged infringement of eleven patents.
Currently before the Court is QDV's motion to dismiss certain claims from the SAC. Specifically, QDV moves to dismiss the following: (i) willful infringement of Patent Nos. 6,207,229 ("229 Patent"), 6,322,901 ("901" Patent"), 8,481,112 ("112 Patent"), 8,481,113 ("113 Patent"), and 6,821,337 ("337 Patent") in Counts One through Four and Six (the "Willful Infringement Claims"); (ii) pre-suit induced infringement claims for Patent No. 9,182,621 ("621 Patent) in Count Thirteen; (iii) contributory infringement of Patent Nos. 8,648,524 ("524 Patent") and 9,063,363 ("363 Patent") in Counts Eleven and Twelve, respectively. (Dkt. No. 88, "Mtn.") The Court previously dismissed these same claims with leave to amend. (Dkt. No. 80.)
Having carefully considered the pleadings and the papers submitted on this motion, and for the reasons set forth more fully below, the Court
First, with regards to the Willful Infringement Claims, QDV argues that plaintiffs have failed to plead allegations showing willfulness beyond mere knowledge, which this Court noted plaintiffs must do in its prior order dismissing the same. With respect to the patents at issue for the Willful Infringement Claims, plaintiffs have added allegations in the SAC demonstrating the following: Nanosys and QDV shared at least one co-founder, Dr. Moungi Bawendi. Dr. Bawendi was also a named inventor of the patents at issue. Dr. Bawendi left Nanosys to found QDV and provide scientific advice to the company. QDV then "availed itself of Dr. Bawendi's knowledge of the claimed inventions and Nanosys's technology to develop and market its infringing products, including Color IQ." (SAC ¶¶ 44, 58, 72, 85, 112.) The Court finds that such allegations constitute more than "mere knowledge" and are, at this stage, sufficient to support a claim for willful infringement. Plaintiffs have alleged that the former founder of Nanosys who is also named as an inventor of the patents at issue used his specific knowledge regarding such patents to develop competing technology at another company. If true, such could constitute egregious actions that would entitle plaintiffs to enhanced damages under the patent laws. See Halo Elec., Inc. v. Pulse Elec., Inc., 136 S.Ct. 1923, 1936 (2016) (acknowledging that "intentional or knowing" infringement "may" warrant a punitive sanction, particularly where the circumstances transform "simple knowledge into such egregious behavior") (Breyer, J., concurring). Accordingly, QDV's motion to dismiss the Willful Infringement Claims is
Second, with regards to the induced infringement claims in Count Thirteen, the Court previously dismissed the pre-suit allegations for failure to allege adequately pre-suit knowledge of the patents. In the SAC, plaintiffs have added allegations regarding Dr. Bawendi's involvement with Nanosys, as discussed above. Additionally, plaintiffs allege that the quantum dot technology market consists primarily of only two companies, namely, QDV and Nanosys. As such, plaintiffs allege that QDV would have monitored developments in Nanosys' technology and intellectual property, and thus knew, or at the very least, should have known, about the issuance of the 621 Patent. QDV argues that such allegations remain insufficient to support pre-suit inducement claims. Specifically, QDV argues that Dr. Bawendi left Nanosys in 2004, almost a decade before the 621 Patent was issued. However, the Court finds that the allegations in the SAC are sufficient to raise at least the inference that QDV knew about the 621 Patent prior to the filing of the instant suit. That QDV and Nanosys are the two primary players in a small market increases the likelihood that QDV had knowledge of Nanosys's patents. See, e.g., 3D Sys., Inc. v. Formlabs, Inc., No. 13-CV-7973, 2014 WL 1904365, at *3 (S.D.N.Y. May 12, 2014) (finding knowledge sufficiently pled where parties were in the same market for stereolithographic 3D printers). Thus, the Court
Finally, with regards to the contributory infringement claims in Counts Eleven and Twelve, the Court previously dismissed the same finding that plaintiffs failed to plead any facts demonstrating that the accused infringing components lacked any substantial non-infringing uses. Plaintiffs have now incorporated by reference their "Disclosure of Asserted Claims and Infringement Contentions" served on September 9, 2016, and claim that the same supports their allegations that QDV's products have no "substantial non-infringing uses." (SAC ¶¶ 165, 185.) Additionally, plaintiffs allege that the accused products are "specially designed and adapted such that it must be used" in the infringing manner claimed in plaintiffs' patents. (Id. at ¶¶ 170-173, 190-193.) QDV no longer appears to challenge plaintiffs' claims on these grounds, but argues that plaintiffs have failed to allege any facts that would show that QDV knew its products were "especially made to infringe" the patents at issue here because plaintiffs have inadequately pled that QDV knew of the patents when QDV created the allegedly infringing products. (See Dkt. No. 92 at 7.) With respect to this issue, plaintiffs have again alleged that, because of the close relationship between Dr. Bawendi and Nanosys and because of the relatively small size of the market (see SAC ¶¶ 163, 183), QDV knew or should have known about the patents at issue. As discussed above, such is sufficient at this stage to raise an inference that QDV had the requisite knowledge to sustain a claim for contributory infringement in Counts Eleven and Twelve.
Accordingly, QDV's motion to dismiss the same is
This Order terminates Docket Number 88.